- Conditions
- Ocular Redness, Eye Irritation
- Interventions
- FID 123320 Ophthalmic Solution, Vehicle
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 5 Years and older
- Enrollment
- 283 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 10
- States / cities
- Azusa, California • Newport Beach, California • Colorado Springs, Colorado + 7 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 457–480
of 622
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Alcohol Use Disorder
- Interventions
- Psilocybin, Inactive Placebo, Supportive therapy sessions
- Drug · Other · Behavioral
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Pregnancy Complications, Sedentary Behavior
- Interventions
- Sedentary Behavior Reduction, Information on Physical Activity Recommendations during Pregnancy
- Behavioral
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Diabetes Mellitus, Type 2, Albuminuria
- Interventions
- Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 5,813 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 57
- States / cities
- Little Rock, Arkansas • Carmichael, California • Concord, California + 54 more
- Conditions
- Diabetes Mellitus, Type 2, Cardiovascular Diseases, Risk Factors
- Interventions
- Placebo, Canagliflozin (JNJ-28431754) 100 mg, Canagliflozin (JNJ-28431754) 300 mg
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 4,330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2017
- U.S. locations
- 58
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Tucson, Arizona + 55 more
- Conditions
- Acute Pain, Chronic Pain, Knee Pain Chronic, Neuropathic Pain
- Interventions
- Venlafaxine 37.5 MG, Placebo
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Bacterial Infections
- Interventions
- XNW4107, Imipenem/Cilastatin, placebo
- Drug
- Lead sponsor
- Evopoint Biosciences Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Open-angle Glaucoma (OAG), Ocular Hypertension (OHT), Glaucoma
- Interventions
- QLS-111, 0.015%, QLS-111, 0.030%, QLS-111, 0.075%, QLS-111 vehicle ophthalmic solution
- Drug
- Lead sponsor
- Qlaris Bio, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Healthy
- Interventions
- Probiotic, Placebo
- Dietary Supplement · Other
- Lead sponsor
- Loyola University
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 8 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Maywood, Illinois
- Conditions
- Recurrent Gastrointestinal Symptoms
- Interventions
- Trenev Trio®/Healthy Trinity®, Placebo
- Dietary Supplement
- Lead sponsor
- Sprim Advanced Life Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012
- U.S. locations
- 5
- States / cities
- Los Angeles, California • San Francisco, California • West Lawn, Pennsylvania + 2 more
- Conditions
- Chronic Low Back Pain, Posttraumatic Stress Disorder
- Interventions
- Progressive exercise training, Waitlist Control
- Behavioral
- Lead sponsor
- Boston University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 1
- States / cities
- Jamaica Plain, Massachusetts
- Conditions
- Quality of Life, Cognitive Decline, Fatigue, Sleep, Anxiety, Depression
- Interventions
- Physical activity experiment, Balance and flexibility control
- Behavioral
- Lead sponsor
- American Cancer Society, Inc.
- Other
- Eligibility
- 55 Years to 77 Years
- Enrollment
- 415 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Kennesaw, Georgia
- Conditions
- Chronic Wound, Diabetes, Spinal Cord Injury, Ischemic Wound
- Interventions
- exciflex
- Device
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2029
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Overweight, Weight Loss
- Interventions
- mDiet
- Behavioral
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 21 Years to 60 Years
- Enrollment
- 318 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Gastroparesis, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
- Interventions
- Placebo, 10mg TZP-102, 20mg TZP-102
- Drug
- Lead sponsor
- Tranzyme, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 201 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 31
- States / cities
- Huntsville, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 27 more
- Conditions
- Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
- Interventions
- ATV-1601, Placebo
- Drug
- Lead sponsor
- Atavistik Bio, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2030
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • Augusta, Georgia • Indianapolis, Indiana + 3 more
- Conditions
- Sleep Quality, Menopause
- Interventions
- Lotus Seed & Rice Germ Extract, Placebo
- Dietary Supplement · Other
- Lead sponsor
- Nutraland USA, Inc.
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Bexagliflozin, Placebo
- Drug
- Lead sponsor
- Theracos
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 210 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 18
- States / cities
- Canoga Park, California • Chino, California • Huntington Park, California + 15 more
- Conditions
- Insulin, Exercise
- Interventions
- Placebo into the intranasal mucosa, 20 IU NovoLog Insulin aspart into the intranasal mucosa, 40 IU NovoLog Insulin aspart into the intranasal mucosa, 60 IU NovoLog Insulin aspart into the intranasal mucosa, 80 IU NovoLog Insulin aspart into the intranasal mucosa, 100 IU NovoLog Insulin aspart into the intranasal mucosa, 120 IU NovoLog Insulin aspart into the intranasal mucosa
- Drug
- Lead sponsor
- Michigan State University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 116 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- East Lansing, Michigan
- Conditions
- Type 2 Diabetes, Sedentary Behavior, Sedentary Time, Physical Activity
- Interventions
- Sit Less Program
- Behavioral
- Lead sponsor
- Vanderbilt University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Fecal Incontinence
- Interventions
- Loperamide, Placebo, Anal exercises with biofeedback, Usual Care
- Drug · Behavioral
- Lead sponsor
- NICHD Pelvic Floor Disorders Network
- Network
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 9
- States / cities
- Birmingham, Alabama • La Jolla, California • San Diego, California + 6 more
- Conditions
- Overweight and Obesity
- Interventions
- ER, SBWC
- Behavioral
- Lead sponsor
- Rhode Island Hospital
- Other
- Eligibility
- 13 Years to 17 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Major Depressive Disorder, Dysthymia, Spinal Cord Injuries
- Interventions
- venlafaxine XR, placebo
- Drug
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 133 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2012
- U.S. locations
- 6
- States / cities
- Birmingham, Alabama • Miami, Florida • Chicago, Illinois + 3 more
- Conditions
- Atopic Dermatitis
- Interventions
- Roflumilast Cream 0.05%, Roflumilast Cream 0.15%, Vehicle Cream
- Drug
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 136 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 17
- States / cities
- Scottsdale, Arizona • San Diego, California • Hialeah, Florida + 14 more